• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.01% Nasdaq Up0.26%

    Myriad Genetics, Inc. (MYGN)

    43.82 Down 0.28(0.63%) Nov 25, 4:00PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.6
    Mean Recommendation (last week):2.7

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:40.50
    Median Target:43.00
    High Target:50.00
    Low Target:25.00
    No. of Brokers:10

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Aug 25, 2015Wells FargoUpgradeMarket PerformOutperform
    Jul 21, 2015Gabelli & CoInitiated Buy
    Mar 10, 2015UBSInitiated Sell
    Feb 4, 2015MizuhoDowngradeBuyNeutral
    Jan 7, 2015BarclaysInitiated Overweight
    Apr 4, 2014MizuhoUpgradeNeutralBuy
    Feb 5, 2014Ladenburg ThalmannDowngradeBuyNeutral
    Dec 30, 2013MizuhoDowngradeBuyNeutral
    Oct 1, 2013Ladenburg ThalmannUpgradeNeutralBuy
    Jun 7, 2013Cantor FitzgeraldInitiated Buy

    More Upgrades & Downgrades for MYGN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy3332

    Data provided by Thomson/First Call

    Currency in USD.